Normalised Returns
Healthcare Service Provider · closest in market valueHEALTHX−8.2%Nifty Pharma+25.7%
Full Comparison
NSE filings · last close| Company | Price | Mkt Cap | P/E | P/B | ROE | Margin | Rev YoY | PAT YoY | D/E | 1Y Rtn |
|---|---|---|---|---|---|---|---|---|---|---|
| THYROCARE | ₹566.85 | ₹9,023 Cr | 51.3× | 15.41× | 28.8% | 19.6% | +24.3% | +34.1% | 0.00× | +44.6% |
| NEPHROPLUS | ₹696.65 | ₹6,990 Cr | – | 6.26× | 6.9% | 7.7% | – | – | 0.07× | – |
| SURAKSHA | ₹343.3 | ₹1,788 Cr | 49.7× | 7.30× | 13.8% | 10.1% | +20.7% | +40.0% | 0.01× | +15.0% |
| KRSNAA | ₹548.45 | ₹1,779 Cr | 18.3× | 1.81× | 10.9% | 13.1% | +22.1% | −19.3% | 0.55× | −28.8% |
| HEALTHX ● | ₹288.65 | ₹918 Cr | – | 1.43× | -0.2% | -0.1% | +49.7% | −92.5% | 0.03× | −8.2% |
| GAUDIUMIVF | ₹115.22 | ₹839 Cr | – | 5.51× | 16.1% | 23.4% | – | – | 0.15× | – |
Healthcare Service Provider: the companies closest in market value, of the 9 in that basic industry whose filings we hold, from each company's NSE filings and the last close. Quarterly figures are for Q1 FY27; ROE, margin for FY26; P/B and D/E on the latest balance sheet. Green and red mark the two ends of a column; valuation and leverage columns are left plain. Hover a heading for its definition.
Against Healthcare Service Provider9 companies
P/E—
18.6×median 55.5× · 6 companies86.1×
P/B1.45×
1.45×median 7.51× · 9 of 9, highest first16.9×
ROE-4.1%
-4.1%median 14.7% · 7 of 7, highest first30.0%
Net margin-1.8%
-1.8%median 12.0% · 7 of 7, highest first21.9%
Revenue growth28.8%
10.2%median 21.1% · 1 of 7, highest first28.8%
Profit growth—
5.4%median 22.9% · 6 companies39.7%
Debt / equity0.03×
0.00×median 0.01× · 4 of 9, highest first0.55×
Dividend yield—
0.1%median 0.6% · 6 companies2.5%
1-year price change-7.0%
-32.5%median 15.0% · 6 of 7, highest first45.5%
Everyone in Healthcare Service Provider whose filings we hold: 9 companies, its basic industry within Healthcare. Figures as the screener works them out (the last four quarters' profit, the latest balance sheet, the last close), so ROE can differ a little from the Financials tab's latest-year figure. A place in the line is a fact about a number, not a view on the company.
HEALTHX Rankings
Among 6 companies compared
Profitability
6
ROE -0.2%Lowest of 66
Net margin -0.1%Lowest of 6Growth
1
Revenue YoY +49.7%Highest of 44
Net profit YoY −92.5%Lowest of 4Leverage
3
Debt / equity 0.03×3rd lowest of 6Valuation
1
P/Book 1.43×Lowest of 6Price
3
1-year return −8.2%3rd highest of 4Position 1 is the lowest NPA, multiple or leverage, and the highest return, growth or profitability figure. These are positions among the companies listed here, not a view on the stock.